Pharmacokinetics and pharmacodynamics of propofol 6% SAZN versus propofol 1% SAZN and Diprivan-10 for short-term sedation following coronary artery bypass surgery

European Journal of Clinical Pharmacology

Volumn 56, Issue 1, 2000, Pages 89-95

  Knibbe, C A J ^a   Aarts, L P H J ^a   Kuks, P F M ^a   Voortman, H J ^a   Lie A Huen, L ^a   Bras, L J ^a   Danhof, M ^b  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Anaesthetics i.v.; Pharmacokinetics; Propofol

Indexed keywords

INTRALIPID; INTRAVENOUS ANESTHETIC AGENT; LIPOFUNDIN; PROPOFOL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISTRIBUTION VOLUME; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG RESEARCH; DRUG SAFETY; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0034028442     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050726     Document Type: Article

References (24)

1. 1. Bryson HM, Fulton BR, Faulds D (1995) Propofol. An update of its use in anaesthesia and conscious sedation. Drugs 50: 513-559
2. 2. Fulton B, Sorkin EM (1995) Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation. Drugs 50: 636-657
3. 3. Boyle WA, Shear JM, White PF, Schuller D (1990) Tolerance and hyperlipemia during long-term sedation with propofol (abstract). Anesthesiology 73[suppl 3A]: A245
4. 4. Cook S, Palma O (1989) Propofol as a sole agent for prolonged infusion in intensive care. J Drug Dev 2[suppl 2]: 65-67
5. 5. Gottardis M, Khünl-Brady KS, Koller W, Sigl G, Hackl JM (1989) Effect of prolonged sedation with propofol on serum triglyceride and cholesterol concentrations. Br J Anaesth 62: 393-396
6. 6. Zeneca Pharma (1998) Product information Diprivan-10. In: Repertorium, 1998/1999. Nefarma and Neprofarm, Utrecht, The Netherlands, pp 916-918
7. 7. Cox EH, Knibbe CAJ, Koster VS, Langemeijer MWE, Tukker EE, Lange R, Kuks PFM, Langemeijer JJM, Lie-A-Huen L, Danhof M (1998) Influence of different fat emulsion-based intravenous formulations on the pharmacokinetics and pharmacodynamics of propofol. Pharm Res 15: 442-448
8. 8. Knibbe CAJ, Voortman HJ, Aarts LPHJ, Kuks PFM, Lange R, Langemeijer JJM, Danhof M (1999) Pharmacokinetics, induction of anaesthesia and safety characteristics of Propofol 6% SAZN versus Propofol 1% SAZN and Diprivan-10 after bolus injection. Br J Clin Pharmacol 47: 653-660
9. 9. Glen JB, Hunter SC (1984) Pharmacology of an emulsion formulation of ICI 35868. Br J Anaesth 56: 617-625
10. 10. Cummings GC, Dixon J, Kay NH, Windsor JPW, Major E, Morgan M, Sear JW, Spence AA, Stephenson DK (1984) Dose requirements of ICI 35,868 (Propofol, 'Diprivan') in a new formulation for induction of anaesthesia. Anaesthesia 39: 1168-1171
11. 11. Dutta S, Matsumoto Y, Ebling WF (1997) Propofol pharmacokinetics and pharmacodynamics assessed from a cremophor EL formulation. J Pharm Sci 86: 967-969
12. 12. Dutta S, Ebling WF (1997) Emulsion formulation reduces propofol dose requirements and enhances safety. Anesthesiology 87: 1394-1405
13. 13. Ramsay MAE, Savege TM, Simpson BRJ, Goodwin R. (1974) Controlled sedation with alphaxalone-alphadolone. BMJ 2: 656-659
14. 14. Knibbe CAJ, Koster VS, Deneer VHM, Stuurman RM, Kuks PFM, Lange R (1998) Determination of propofol in low volume samples by high-performance liquid chromatography with fluorescence detection. J Chromatogr B Biomed Sci Appl 706: 305-310
15. 15. Gibaldi M, Perrier D (1982) Noncompartmental analysis based on statistical moment theory. In: Gibaldi M, Perrier D (eds) Pharmacokinetics, 2nd edn. Marcel Dekker, New York, pp 409-424
16. 16. Kay NH, Sear JW, Uppington J, Cockshott ID, Douglas EJ (1986) Disposition of propofol in patients undergoing surgery. A comparison in men and women. Br J Anaesth 58: 1075-1079
17. 17. Cockshott ID, Briggs LP, Douglas KJ, White M (1987) Pharmacokinetics of propofol in female patients. Studies using single bolus injections. Br J Anaesth 59: 1103-1110
18. 18. Kanto J, Gepts E (1989) Pharmacokinetic implications for the clinical use of propofol. Clin Pharmacokinet 17: 308-326
19. 19. Gin T, Gregory MA, Chan K, Buckley, Oh TE (1990) Pharmacokinetics of propofol in women undergoing elective Caesarean section. Br J Anaesth 64: 148-153
20. 20. Gepts E, Camu F, Cockshott ID, Douglas EJ (1987) Disposition of propofol administered as constant rate intravenous infusions in humans. Anesth Analg 66: 1256-1263
21. 21. Schnider TW, Minto CF, Gambus PL, Andresen C, Goodale DB, Shafer SL, Youngs EJ (1998) The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 88: 1170-1182
22. 22. Leslie K, Sessler DI, Bjorksten AR, Moayeri A (1995) Mild hypothermia alters propofol pharmacokinetics and increases the duration of action of atracurium. Anesth Analg 80: 1007-1014
23. 23. Barr J, Egan T, Feeley T, Shafer S (1992) Depth of sedation vs propofol concentration in mechanically ventilated ICU patients (abstract). Anesthesiology 77[suppl 3A]: A313
24. 24. Miles PS, Buckland MR, Morgan DJ, Weeks AM (1995) Serum lipid and glucose concentrations with a propofol infusion for cardiac surgery. J Cardiothorac Vasc Anesth 9: 373-378